Kimball Electronics FY2026 10-K: Net Income Up 65% to $28M, Helvoet Acquisition Closed
KE is trading near its 52-week low of $21.01 (13% above the low).
Summary
Kimball Electronics' FY2026 10-K shows net income up 65% to $28M, a restated credit facility, and the completed $103M Helvoet acquisition, offset by an $8.9M withholding tax charge.
Key Events · Earnings and Guidance · KE
-
FY2026 Net Income Up 65%
Net income rose to $28.0 million from $17.0 million, with diluted EPS of $1.13 versus $0.68, driven by gross margin improvement and a $15 million gain on the Tampa facility sale.
-
Helvoet Acquisition Closed
Completed July 1, 2026 for approximately €90 million (~$103 million), funded with cash and existing credit lines; expands precision molded plastics and medical CDMO capabilities.
-
Dividend Withholding Tax Hit
Recorded $8.9 million in dividend withholding tax expense in the Netherlands, including $4.4 million from Poland and $4.5 million from China, pushing the effective tax rate to 47.5%.
-
Credit Facility Extended to 2031
Amended and restated primary credit facility on April 30, 2026, extending maturity to April 30, 2031, with $300 million revolving capacity and $92.5 million term loan outstanding.
Analysis · KE · Manufacturing
A strong fiscal 2026 saw net income climb 65% to $28.0 million and diluted EPS rise 66% to $1.13, driven by gross margin expansion and a $15 million gain on the Tampa facility sale. The balance sheet remains solid with $88.9 million in cash and a restated credit facility extending maturity to 2031. The Helvoet acquisition, closed July 1, 2026 for approximately $103 million, expands the company's medical CDMO capabilities but adds integration risk and debt. The 10-K also reveals an $8.9 million dividend withholding tax expense from unfavorable rulings in Poland and China, a one-time hit that inflated the effective tax rate to 47.5%.
At the time of this filing, KE was trading at $23.72 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $570.4M. The 52-week trading range was $21.01 to $33.19. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.